CTRI/2015/02/005522
Recruiting
Phase 4
Multicentric follow up study to evaluate the immunogenicity of Single dose Live Attenuated Varicella Vaccine (VR 795 varicella Oka strain) in healthy Indian children up to 5 years post-vaccination.
Wockhardt Ltd0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Wockhardt Ltd
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •. Healthy children of either sex who received test varicella vaccination (VR 795 varicella Oka strain) as part of the Phase III clinical trial (WOC/VAC/VAR/CT\-19\-PRT)
- •. Parent/guardian of subject willing to give written ICF and to comply to all study related procedures
Exclusion Criteria
- •. Subjects who have not received test varicella vaccine (VR 795 varicella Oka strain) as part of the Phase III clinical trial (WOC/VAC/VAR/CT\-19\-PRT)
- •. Any other criteria considered by the Investigator not to be suitable for enrollment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A clinical study to assess the continued immunological existence of antibodies at 12, 24 and 36 months after receiving the primary dose.Health Condition 1: Z23- Encounter for immunizationCTRI/2020/03/023712Biological ELimited233
Not yet recruiting
Phase 4
A 9th year follow up study on persitance of Hepatitis A vaccineCTRI/2017/02/007837Wockhardt Ltd150
Active, not recruiting
Phase 1
A multicenter, pilot study evaluating immune impact and safety of nivolumab in combination with ipilimumab (immune combination) before initial RT-CT treatment for cervix cancer. COLIBRI StudyPatients with cervical squamous cell carcinoma stage IB3 to IVaMedDRA version: 21.1Level: LLTClassification code 10008233Term: Cervical cancer stage ISystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10008234Term: Cervical cancer stage IISystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10008235Term: Cervical cancer stage IIISystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10008236Term: Cervical cancer stage IVSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2019-002271-34-FRARCAGY-GINECO40
Recruiting
Not Applicable
Multi-institutional study of immunologic response tu surgical stress in patients undergoing pulmonary lobectomyung cancerJPRN-UMIN000021182agoya City University100
Active, not recruiting
Not Applicable
A multicenter study to describe the immunogenic epitope(s) of factor VIII in previously treated patients with congenital hemophilia A who develop de novo factor VIII inhibitors while receiving factor VIII infusion therapy - N/AHaemophilia A is an X-linked recessive clotting disorder in which the clotting factor, factor VIII (FVIII), is deficient or inactive. Patients with low levels of FVIII have an increased tendency to bleed and is characterised by recurrent haemorrhages due to trauma, surgery or spontaneous haemorrhaging when the condition is severe.EUCTR2004-000219-24-DEWyeth Pharmaceuticals27